Stock listing
A40ZAV Stock Price, News, Filings & Events — Mink Therapeutics, Inc.
Selected listing: A40ZAV · LS · EUR · DE
This page tracks Mink Therapeutics, Inc.'s A40ZAV:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A40ZAV:LS. A40ZAV:LS is the stock-level entry point for investors researching Mink Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A40ZAV:LS
- Asset type
- Stock
- Market cap
- $61.2M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LS
- Currency
- EUR
Mink Therapeutics, Inc. A40ZAV:LS stock context
This page tracks Mink Therapeutics, Inc.'s A40ZAV:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A40ZAV:LS. A40ZAV:LS is the stock-level entry point for investors researching Mink Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Mink Therapeutics, Inc.
MiNK Therapeutics Reports Second Quarter 2026 Financial Results and Reports Observations from Randomized Phase 2 Trial of agenT-797 in Ac...
August 13, 2026
MiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting
June 3, 2026
MiNK Therapeutics Announces First Patient Dosed in Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness
May 28, 2026
MiNK Therapeutics Reports New Data on agenT-797, an allo-iNKT Cell Therapy at ATS 2026; Simultaneously Published in Clinical Immunology C...
May 20, 2026
MiNK Therapeutics Reports First Quarter 2026 Financial Results and Advances iNKT Cell Therapy Platform Into Randomized Clinical Validation
May 15, 2026
Mink Therapeutics, Inc. earnings calls
MiNK Therapeutics, Inc. (INKT) Q2 2026 Earnings Call
August 13, 2026 · Replay with transcript and chapters
MiNK Therapeutics, Inc. (INKT) Q1 2026 Earnings Call
May 15, 2026 · Replay with transcript and chapters
MiNK Therapeutics, Inc. (INKT) Q4 2025 Earnings Call
March 31, 2026 · Replay with transcript and chapters
MiNK Therapeutics, Inc. (INKT) Q3 2025 Earnings Call
November 14, 2025 · Replay with transcript and chapters
MiNK Therapeutics, Inc. (INKT) Q2 2025 Earnings Call
August 14, 2025 · Replay with transcript and chapters
MiNK Therapeutics, Inc. (INKT) Q1 2025 Earnings Call
May 15, 2025 · Replay with transcript and chapters
Research Mink Therapeutics, Inc.
Mink Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for A40ZAV:LS.
Mink Therapeutics, Inc. company profile
View the public company page for Mink Therapeutics, Inc. on 6ix.
Mink Therapeutics, Inc. news
Read company news and market updates connected to Mink Therapeutics, Inc..
Mink Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Mink Therapeutics, Inc..
Alternate listings
INKT:NASDAQ
US · USD
Alternate listing for Mink Therapeutics, Inc.; the primary context on this page is A40ZAV:LS.
A40ZAV:LSX
DE · EUR
Alternate listing for Mink Therapeutics, Inc.; the primary context on this page is A40ZAV:LS.
INKT:BOATS
US · USD
Alternate listing for Mink Therapeutics, Inc.; the primary context on this page is A40ZAV:LS.
6Q40:GETTEX
DE · EUR
Alternate listing for Mink Therapeutics, Inc.; the primary context on this page is A40ZAV:LS.
6Q40:FWB
DE · EUR
Alternate listing for Mink Therapeutics, Inc.; the primary context on this page is A40ZAV:LS.
6Q40:MUN
DE · EUR
Alternate listing for Mink Therapeutics, Inc.; the primary context on this page is A40ZAV:LS.
6Q40:TRADEGATE
DE · EUR
Alternate listing for Mink Therapeutics, Inc.; the primary context on this page is A40ZAV:LS.